Faron Pharmaceuticals Oy (FARN) — Capital Reinvestment Ratio

Latest as of January 2015: 0.21x

Faron Pharmaceuticals Oy (FARN) has a Capital Reinvestment Ratio of 0.21x as of January 2015, meaning it reinvests 0% of its operating cash flow (GBX178.50) in capital expenditures (GBX38.00). See Faron Pharmaceuticals Oy (FARN) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.21x

Capex / Operating Cash Flow

Operating Cash Flow

GBX178.50

GBX

Capital Expenditures

GBX38.00

GBX

Data as of

Jan 2015

Most recent filing

Annual Capital Reinvestment Ratio for Faron Pharmaceuticals Oy (None–None)

Year-by-year Capital Reinvestment Ratio for Faron Pharmaceuticals Oy from None to None. For live market cap and broader valuation context, see Faron Pharmaceuticals Oy (FARN) market capitalisation.

Year	Reinvestment Ratio	Operating CF (GBX)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow